The Mark H Zangmeister Cancer Center — Nashville, Tennessee

The Mark H Zangmeister Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

The Mark H Zangmeister Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H Zangmeister Cancer Center?

The Mark H Zangmeister Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H Zangmeister Cancer Center conducted?

The Mark H Zangmeister Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Neoplasm Metastasis.

Is The Mark H Zangmeister Cancer Center accredited by Crixeo Health?

The Mark H Zangmeister Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H Zangmeister Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.